ZRANB3 and cancer: Finally, our structural and biochemical analyses enable us to assess the functional relevance of cancer associated mutations of ZRANB3. We demonstrate a high incidence of impaired and/or loss-of-function mutations that likely contribute to genomic instability in this context.